Expertise in
3
conditions

Dr. Mohammad K. Khan

Internal Medicine
Quest Diagnostics Clinical Laboratories Inc
1330 Boiling Springs Rd, 
Spartanburg, SC 
Expertise in
3
conditions
Quest Diagnostics Clinical Laboratories Inc
1330 Boiling Springs Rd, 
Spartanburg, SC 

Overview

Mohammad Khan is a primary care provider, practicing in Internal Medicine in Spartanburg, South Carolina.

Dr. Khan is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), Pneumonia, T-Cell Lymphoma, and Non-Hodgkin Lymphoma.

He is actively involved in clinical research, co-authoring 107 peer reviewed articles and participating in 7 clinical trials.

Specialties

Internal Medicine

Licenses

Internal Medicine in SC

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO

Locations

Quest Diagnostics Clinical Laboratories Inc
1330 Boiling Springs Rd, Spartanburg, SC 29303

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Safety and Efficacy of SRS and Immune Checkpoint Inhibitors (ICI) Concurrent With NovoTTF-200M in Melanoma Brain Metastases
Safety and Efficacy of SRS and Immune Checkpoint Inhibitors (ICI) Concurrent With NovoTTF-200M in Melanoma Brain Metastases
Enrollment Status: Terminated
Publish Date: April 23, 2026
Intervention Type: Biological, Radiation, Procedure
Study Phase: Phase 1
Pilot Study of Pembrolizumab and Stereotactic Radio-Surgery (SRS) for Patients With Melanoma or Non-Small Cell Lung Cancer (NSCLC) Brain Metastases (BM)
Pilot Study of Pembrolizumab and Stereotactic Radio-Surgery (SRS) for Patients With Melanoma or Non-Small Cell Lung Cancer (NSCLC) Brain Metastases (BM)
Enrollment Status: Completed
Publish Date: March 09, 2026
Intervention Type: Radiation, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 1
postMONARCH: A Randomized, Double Blind, Placebo-Controlled, Phase 3 Study to Compare the Efficacy of Abemaciclib Plus Fulvestrant to Placebo Plus Fulvestrant in Participants With HR+, HER2-, Advanced or Metastatic Breast Cancer Following Progression on a CDK4 & 6 Inhibitor and Endocrine Therapy
postMONARCH: A Randomized, Double Blind, Placebo-Controlled, Phase 3 Study to Compare the Efficacy of Abemaciclib Plus Fulvestrant to Placebo Plus Fulvestrant in Participants With HR+, HER2-, Advanced or Metastatic Breast Cancer Following Progression on a CDK4 & 6 Inhibitor and Endocrine Therapy
Enrollment Status: Active_not_recruiting
Publish Date: January 16, 2026
Intervention Type: Drug
Study Drugs: Abemaciclib, Fulvestrant
Study Phase: Phase 3
eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
Enrollment Status: Terminated
Publish Date: July 15, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19 (RESCUE 1-19): A Randomized Phase III Trial of Best Supportive Care Plus Provider's Choice of Pharmaceutical Treatment With or Without Whole Lung Low-Dose Radiation Therapy (LD-RT) in Hospitalized Patients With COVID-19
Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19 (RESCUE 1-19): A Randomized Phase III Trial of Best Supportive Care Plus Provider's Choice of Pharmaceutical Treatment With or Without Whole Lung Low-Dose Radiation Therapy (LD-RT) in Hospitalized Patients With COVID-19
Enrollment Status: Unknown
Publish Date: August 14, 2023
Intervention Type: Other, Radiation
Study Phase: Phase 3
The RESCUE 1-19 Trial: Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19
The RESCUE 1-19 Trial: Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19
Enrollment Status: Terminated
Publish Date: March 29, 2022
Intervention Type: Radiation
Study Phase: Phase 1/Phase 2
View 5 Less Clinical Trials

107 Total Publications

Anti-inflammatory role of radiation therapy for pilot treatment of refractory erosive pustular dermatosis of the scalp.
Anti-inflammatory role of radiation therapy for pilot treatment of refractory erosive pustular dermatosis of the scalp.
Journal: JAAD case reports
Published: September 05, 2026
Similar Doctors
Expertise in
51
conditions
Dr. Victoria A. Arlauskas
Internal Medicine
Expertise in
51
conditions
Dr. Victoria A. Arlauskas
Internal Medicine
Before you request

Medical Group Of The Carolinas-Internal Medicine-Westside

8311 Warren H Abernathy Hwy, 
Spartanburg, SC 
 (5.4 miles away)
864-560-9435
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Victoria Arlauskas is a primary care provider, practicing in Internal Medicine in Spartanburg, South Carolina. Dr. Arlauskas is highly rated in 51 conditions, according to our data. Her clinical expertise encompasses High Cholesterol, Hypertension, Glucocorticoid-Remediable Aldosteronism, and Familial Hypertension. Dr. Arlauskas is currently accepting new patients.

Expertise in
33
conditions
Dr. Abderrahim Khomani
Internal Medicine
Expertise in
33
conditions
Dr. Abderrahim Khomani
Internal Medicine

Spartanburg Regional Healthcare Systems

101 E Wood St, 
Spartanburg, SC 
 (1.6 miles away)
864-560-7050
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Abderrahim Khomani is a primary care provider, practicing in Internal Medicine in Spartanburg, South Carolina. Dr. Khomani is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer. Dr. Khomani is currently accepting new patients.

Expertise in
62
conditions
Dr. Suzanne D. Kovacs
Internal Medicine
Expertise in
62
conditions
Dr. Suzanne D. Kovacs
Internal Medicine
Before you request

Medical Group Of The Carolinas-Internal Medicine-Eastside

1650 Skylyn Dr Ste 220, 
Spartanburg, SC 
 (6.4 miles away)
864-560-9056
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Suzanne Kovacs is a primary care provider, practicing in Internal Medicine in Spartanburg, South Carolina. Dr. Kovacs is highly rated in 62 conditions, according to our data. Her clinical expertise encompasses Familial Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, and Cirrhosis. Dr. Kovacs is currently accepting new patients.

Frequently Asked Questions about Dr. Mohammad K. Khan

How do I make an appointment with Dr. Mohammad K. Khan?

You can book an appointment with Dr. Mohammad K. Khan by calling their office at 864-582-7025. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mohammad K. Khan a top-rated expert for Cutaneous T-Cell Lymphoma (CTCL)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mohammad K. Khan is classified as an Advanced expert for Cutaneous T-Cell Lymphoma (CTCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mohammad K. Khan specialize in?

While Dr. Mohammad K. Khan is a Internal Medicine, they have specific expertise in Cutaneous T-Cell Lymphoma (CTCL), Pneumonia, and T-Cell Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Mohammad K. Khan participate in research or clinical trials?

Yes. Dr. Mohammad K. Khan has published 107 articles and abstracts on conditions like Cutaneous T-Cell Lymphoma (CTCL). You can view a list of Dr. Mohammad K. Khan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mohammad K. Khan accept my insurance?

Dr. Mohammad K. Khan accepts most major insurance plans, including Blue Cross Blue Shield. We recommend calling the office directly at 864-582-7025 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Khan's expertise for a condition
ConditionClose
      View All 21 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile